Top > Search of International Patents > Methods of treating allergies using TGF-β1 and allergens

Methods of treating allergies using TGF-β1 and allergens

Foreign code F100002265
File No. P05-028US
Posted date Sep 30, 2010
Country United States of America
Application number 36337106
Gazette No. 20070048328
Gazette No. 7744895
Date of filing Feb 28, 2006
Gazette Date Mar 1, 2007
Gazette Date Jun 29, 2010
Priority data
  • P2005-252912 (Aug 31, 2005) JP
Title Methods of treating allergies using TGF-β1 and allergens
Abstract (US7744895)
The invention provides an allergy prevention method or treatment method, diets and oral drugs enabling prevention/treatment of allergic symptoms without trouble such as systemic adverse reaction, immune deficiency and the like caused by transdermal/intravenous administration of TGF-&bgr;.
The allergy prevention method or treatment method is to orally administer 100 μg/kg or more of transforming growth factor-beta (TGF-&bgr;) relative to a weight of an administration target body and thereby selectively suppress Th2 immune response, while with respect to the diets and oral drugs, the content is set to contain an effective amount of transforming growth factor-beta (TGF-&bgr;) therein.
Scope of claims [claim1]
1. A method of treating a food allergy, wherein said method comprises: providing isolated transforming growth factor beta 1 (TGF-beta 1) in an amount of 100 mu g/kg to 250 mu g/kg, relative to a weight of an administration target body,
providing a causal substance of allergy,
combining the isolated TGF-beta 1 and causal substance of allergy,
administering orally and simultaneously the combination to the administration target body in need thereof,
wherein said causal substance of allergy is at least one food allergen and,
wherein the method of treating allergy results in a non-transient immunological response;
thereby treating the food allergy.
[claim2]
2. The allergy treatment method according to claim 1, wherein the TGF-beta 1 is human TGF-beta 1.
[claim3]
3. The method according to claim 1, wherein said administration target body is a human.
[claim4]
4. The method according to claim 1, wherein said administration target body is a mouse.
[claim5]
5. The method according to claim 1, wherein the combination is administered every other day for a total of six dosages.
[claim6]
6. The method of treating allergy according to claim 1, wherein 5 mu g of TGF-beta 1 are administered simultaneously with oral intake of the causal substance of allergy, to a mouse.
[claim7]
7. The method according to claim 1, wherein the causal substance of allergy is administered to the target body in an amount of from 3 to 5 mg per gram of target body weight.
[claim8]
8. The method of claim 1, wherein the food allergen is selected from the group consisting of milk, egg, rice, buckwheat, seafood and mixtures thereof.
[claim9]
9. The method of claim 1, wherein the causal substance of allergy is ovalbumin of an egg.
[claim10]
10. The method of claim 1, wherein the food allergen is in a milk product.
[claim11]
11. The method of claim 1, wherein the food allergen is in a rice cake.
[claim12]
12. The method of claim 1, wherein the food allergen is in a yogurt.
[claim13]
13. The method of claim 1, wherein the food allergen is in a noodle.
[claim14]
14. The method of claim 1, wherein the food allergen is in a flour.
[claim15]
15. The method of claim 1, wherein the food allergen is in a pancake mix.
[claim16]
16. The method of claim 1, wherein the food allergen is in a chocolate.
[claim17]
17. The method of claim 1, wherein the food allergen is in a biscuit.
[claim18]
18. The method of claim 1, wherein the food allergen is in a pudding.
  • Inventor, and Inventor/Applicant
  • NAKAO ATSUHITO
  • YAMANASHI UNIVERSITY
IPC(International Patent Classification)
Please feel free to contact us by email or facsimile if you have any interests in this patent.

PAGE TOP

close
close
close
close
close
close